TransAct director converts RSUs into common stock

TransAct Technologies director Haydee Olinger reported multiple equity award conversions into common stock.

Rhea-AI Filing Summary

TransAct Technologies director Haydee Olinger reported multiple equity award conversions into common stock. On February 27, 28 and March 1–2, 2026, Restricted Stock Units granted under the company’s 2014 Equity Incentive Plan converted to common stock on a one-for-one basis at a price of $0.00 per share.

The transactions reflect derivative exercises or conversions, increasing directly held common stock through vesting of prior RSU grants from 2022, 2023, 2024 and 2025, each vesting 25% annually starting on the first anniversary of grant.

Insider Trade Summary

7,375 shares exercised/converted

Exercise 8 txns

Insider Olinger Haydee

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,250	$0.00	$0.00
Exercise	Common Stock	1,250	$0.00	$0.00
Exercise	Restricted Stock Units	1,600	$0.00	$0.00
Exercise	Common Stock	1,600	$0.00	$0.00
Exercise	Restricted Stock Units	1,675	$0.00	$0.00
Exercise	Common Stock	1,675	$0.00	$0.00
Exercise	Restricted Stock Units	2,850	$0.00	$0.00
Exercise	Common Stock	2,850	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 13,500 contracts (Direct); Common Stock — 34,560 shares (Direct)

Footnotes (4)

1. F1. Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
2. F2. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
3. F3. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
4. F4. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did TransAct Technologies (TACT) report for Haydee Olinger?

Haydee Olinger reported exercises of Restricted Stock Units that converted into common stock. These were derivative exercises at $0.00 per share, reflecting vesting of prior equity awards under TransAct Technologies’ 2014 Equity Incentive Plan, rather than open-market purchases or sales.

Which types of securities were involved in the TACT Form 4 for Haydee Olinger?

The Form 4 shows activity in Restricted Stock Units and the corresponding common stock. RSUs granted under the 2014 Equity Incentive Plan vested and converted on a one-for-one basis into common shares, changing Olinger’s direct equity mix from derivative awards to common stock.

On what dates did Haydee Olinger’s TransAct Technologies RSUs convert to common stock?

The RSU conversions occurred on February 27, 2026, February 28, 2026, March 1, 2026, and March 2, 2026. Each date reflects a portion of previously granted awards vesting and converting into common stock under the company’s equity incentive plan.

What was the exercise price for Haydee Olinger’s TransAct Technologies RSU conversions?

The reported exercise or conversion price for each RSU-to-common-stock transaction was $0.00 per share. This is typical for Restricted Stock Units, which convert into common stock upon vesting without additional cash payment from the reporting person.

Under which plan were Haydee Olinger’s TransAct Technologies RSUs granted?

The RSUs were issued under TransAct Technologies’ 2014 Equity Incentive Plan, as Amended and Restated. Footnotes indicate grants made in 2022, 2023, 2024 and 2025, each vesting 25% annually starting on the first anniversary of the respective grant date.

Did Haydee Olinger’s Form 4 for TransAct Technologies indicate open-market buying or selling?

The filing shows exercises or conversions of derivative securities, not open-market buying or selling. All transactions use code “M” for derivative exercise or conversion, with RSUs converting into common stock at $0.00 per share under the company’s equity incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olinger Haydee

(Last) (First) (Middle)

2319 WHITNEY AVENUE, SUITE 3B

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		M		2,850	A	(1)	30,035	D
Common Stock	02/28/2026		M		1,675	A	(2)	31,710	D
Common Stock	03/01/2026		M		1,600	A	(3)	33,310	D
Common Stock	03/02/2026		M		1,250	A	(4)	34,560	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/27/2026		M			2,850	(1)	(1)	Common Stock	2,850	(1)	8,550	D
Restricted Stock Units	(2)	02/28/2026		M			1,675	(2)	(2)	Common Stock	1,675	(2)	3,350	D
Restricted Stock Units	(3)	03/01/2026		M			1,600	(3)	(3)	Common Stock	1,600	(3)	1,600	D
Restricted Stock Units	(4)	03/02/2026		M			1,250	(4)	(4)	Common Stock	1,250	(4)	0	D

Explanation of Responses:

1. Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

2. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

3. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

4. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

	/s/ Madison Gallagher, Attorney-in-Fact for Haydee Olinger	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.